相关实验视频

Updated: May 28, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

313

针对不同HIV-1亚型的Vpr蛋白的抑制分子的计算机辅助设计

Joyeeta Datta1, Satyabrata Majumder1, Kalyan Giri1

  • 1Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, 700073 India.

In silico pharmacology
|February 11, 2025
PubMed
概括

研究人员开发了两种新的小分子来抑制所有人类免疫缺陷病毒1型 (HIV-1) 亚型的Vpr蛋白. 这些潜在的抑制剂向关键的病毒蛋白,为HIV-1治疗提供了新的治疗策略.

关键词:
具有约束力的能源计算药物设计 药物设计药物可的口袋袋可以使用.艾滋病毒-1亚型 艾滋病毒-1亚型这是一种Vpr蛋白质.

更多相关视频

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.0K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.8K

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K